中文 | English
Return
Total: 412 , 1/42
Show Home Prev Next End page: GO
Author:(Xin BI)

1.Research progress on strategies to target intestinal microbiota to improve drug resistance in tumor immunotherapy

Hui-ling LI ; Bi-qing LIU ; Ying-nan FENG ; Xin HU ; Lan ZHANG ; Xian-zhe DONG

Acta Pharmaceutica Sinica 2025;60(2):260-268

2.Acupuncture based on "status-target coherence" theory combined with Kegel exercises for vaginal laxity syndrome: a randomized controlled trial.

Yujing ZHAO ; Yunshu FENG ; Xin DU ; Hong BI ; Yang WANG ; Xiuhua FAN

Chinese Acupuncture & Moxibustion 2025;45(1):31-35

3.Pharmacokinetics study of Dayuanyin in normal and febrile rats.

Yu-Jie HOU ; Kang-Ning XIAO ; Jian-Yun BI ; Xin-Jun ZHANG ; Xin-Rui LI ; Yu-Qing WANG ; Ming SU ; Xin-Ru SUN ; Hui ZHANG ; Bo-Yang WANG ; Li-Jie WANG ; Shan-Xin LIU

China Journal of Chinese Materia Medica 2025;50(2):527-533

4.Quality evaluation of Commelina communis medicinal materials from different origins based on content of four alkaloid components combined with chemometrics.

Bi-Ru FU ; Wei-Jie ZHUO ; Xuan-Xiu HUANG ; Peng-Cong LU ; Xin HE ; Rui-Feng JI

China Journal of Chinese Materia Medica 2025;50(9):2422-2431

5.Identification of tissue distribution components and mechanism of antipyretic effect of famous classical formula Dayuanyin.

Yu-Jie HOU ; Kang-Ning XIAO ; Jian-Yun BI ; Xin-Rui LI ; Ming SU ; Li-Jie WANG ; Yu-Qing WANG ; Dan-Dan SUN ; Hui ZHANG ; Xin-Jun ZHANG ; Shan-Xin LIU

China Journal of Chinese Materia Medica 2025;50(10):2810-2824

6.Growth and development patterns of Noonan syndrome and advances in the treatment of short stature.

Xin LI ; Tian WEN ; Bi-Yun FENG ; Xiu-Min WANG

Chinese Journal of Contemporary Pediatrics 2025;27(1):33-38

7.Non-pharmacological interventions in chronic prostatitis/chronic pelvic pain syndrome: A network meta-analysis.

Xiao-Hui WEI ; Meng-Yao MA ; Hang SU ; Tong HU ; Yu-Xin ZHAO ; Xing-Chao LIU ; Hong-Yan BI

National Journal of Andrology 2025;31(3):234-245

8.Rosmarinic acid ameliorates acute liver injury by activating NRF2 and inhibiting ROS/TXNIP/NLRP3 signal pathway

Jun-fu ZHOU ; Xin-yan DAI ; Hui LI ; Yu-juan WANG ; Li-du SHEN ; DU Xiao-bi A ; Shi-ying ZHANG ; Jia-cheng GUO ; Heng-xiu YAN

Acta Pharmaceutica Sinica 2024;59(6):1664-1673

9.Correlation of CD200-CD200R axis and diseases and its research progress

Han XU ; Yu-xin BI ; Gui-xia LI ; Jian LI ; Liu-li WANG ; Rui-jia HAO ; Xue-min ZHENG ; Rui-jing HUANG ; Jin HAN ; Fei LI ; Gen-bei WANG

Acta Pharmaceutica Sinica 2024;59(4):822-830

10.Study on quality evaluation of Gegen Qinlian decoction based on UHPLC fingerprint and multi-component quantification

Juan XIE ; Qi TANG ; Pan ZHANG ; Xin LI ; Kai-shun BI ; Qing LI

Acta Pharmaceutica Sinica 2024;59(8):2365-2371

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 412 , 1/42 Show Home Prev Next End page: GO